• Company
• Sales of SGLT-2 diabetes drugs increased by 15%
• by Apr 28, 2022 06:06am

• Policy
• Reviewing the removal of outdoor masks
• by Lee, Jeong-Hwan Apr 28, 2022 06:06am

• Company
• Who will follow SK Bio with its homegrown COVID-19 vaccine?
• by Kim, Jin-Gu Apr 28, 2022 06:06am

• Product
• Aftermath of Revlimid of primary benefit multiple myeloma
• by Whang, byung-woo Apr 28, 2022 06:06am

• Company
• Novartis' anticancer drug/Rx division will be merged
• by Eo, Yun-Ho Apr 27, 2022 06:04am

• Opinion
• [Reporter’s View]Recall the purpose of regulating biologics
• by Apr 27, 2022 06:04am

• Company
• Additional formulations of Abbvie’s Skyrizi were approved
• by Eo, Yun-Ho Apr 27, 2022 06:04am

• Policy
• The transition team operates biohealth regulatory sandboxes
• by Kang, Shin-Kook Apr 27, 2022 06:03am

• Policy
• Betamethasone's permission change is expected
• by Lee, Hye-Kyung Apr 27, 2022 06:03am

• Company
• Benefit of Pfizer's Cibinqo is applied
• by Eo, Yun-Ho Apr 26, 2022 06:12am